EN DE
Your region: EU (without Germany)

Your region: EU (without Germany)
Shop By

Filter by:

  1. Remove This Item Species: Human
  2. Remove This Item Origin of cells: genital tract
Clear All

Filter

Reference type
  1. application note (57)
  2. publication (213)
Common cell type
  1. cell line (260)
  2. primary cell (3)
  3. stem cell (4)
  4. unknown (3)
Nucleic acid / Delivered molecule
  1. plasmid (194)
  2. bacmid (6)
  3. oligonucleotide (7)
  4. siRNA (56)
  5. miRNA (3)
  6. sgRNA (2)
  7. peptide (1)
Application
  1. stable transfection (18)
  2. RNA-Interference (67)
  3. virusproduction (3)
  4. cotransfection (plasmid/plasmid) (10)
  5. cotransfection (plasmid/siRNA) (4)
  6. cotransfection (plasmid/miRNA) (1)
  7. cotransfection (plasmid/sgRNA) (2)
  8. CRISPR (8)
Product
  1. Metafectene (121)
  2. Metafectene EASY (15)
  3. Metafectene PRO (75)
  4. Metafectene SI (8)
  5. Metafectene FluoR (1)
  6. K2 Transfection System (39)
  7. K4 Transfection System (4)
  8. DOTAP (7)

References

Set Descending Direction

1-25 of 270

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Products Transfection
Free Sample Offer

Instruction for Use:

In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.

No reference? > General Selection Guide

If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.



CELL TYPE DESCRIPTION OF CELL TYPE CAT.NO. SPECIES ORIGIN OF CELLS COMMON CELL TYPE GROWTH PROPERTIES NUCLEIC ACID / DELIVERED MOLECULE APPLICATION PRODUCT REFERENCE TYPE BIBLIOGRAPHIC DATA PDF LINK

22Rv1

 Human prostate epithelial cancer cell line ATCC CRL-2505 Human genital tract cell line adherent plasmid Metafectene publication M. Ansems et al., The Prostate, 2012, 72: 1708-1717, DOI 10.1002/pros.22522

6E4 HeLaT

 Human cervix adenocarcinoma cell line (derivative of HeLa) Human genital tract cell line adherent plasmid CRISPR Metafectene publication D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3

6E4 HeLaT

 Human cervix adenocarcinoma cell line (derivative of HeLa) Human genital tract cell line adherent sgRNA cotransfection (plasmid/sgRNA) Metafectene publication D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3

6E4 HeLaT

 Human cervix adenocarcinoma cell line (derivative of HeLa) Human genital tract cell line adherent plasmid cotransfection (plasmid/sgRNA) Metafectene publication D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3

6E4 HeLaT

 Human cervix adenocarcinoma cell line (derivative of HeLa) Human genital tract cell line adherent sgRNA CRISPR Metafectene publication D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3

A-2780

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K2 Transfection System publication M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn Link

A-2780

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K4 Transfection System publication S. Möltgen et al., Cells, 2020, 9, 1322, doi:10.3390/cells9061322 Link

A-2780

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference Metafectene PRO publication C. P. Masamha et al., Cancer Res., Aug 2009; 69: 6565 - 6572 Link

A-2780

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K2 Transfection System application note

A-2780

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K4 Transfection System application note

A-2780

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K2 Transfection System application note

A-2780

 Human ovarian carcinoma cell line Human genital tract cell line adherent plasmid stable transfection Metafectene PRO publication C.F.T. Taute, PhD Thesis, 2013, University of the Western Cape Link

A-2780

 Human ovarian carcinoma cell line Human genital tract cell line adherent plasmid Metafectene PRO publication C. P. Masamha et al., Cancer Res., Aug 2009; 69: 6565 - 6572 Link

A-2780cis

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K4 Transfection System application note

A-2780cis

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K2 Transfection System application note

A-2780cis

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K2 Transfection System publication M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn Link

A-2780cis

 Human ovarian carcinoma cell line Human genital tract cell line adherent siRNA RNA-Interference K2 Transfection System application note

C4-2

 Human prostate carcinoma cell line (derivative of LNCaP) Human genital tract cell line adherent plasmid stable transfection Metafectene PRO publication R.C. Peery, Dissertation,, 2020, Indiana University Link

C4-2

 Human prostate carcinoma cell line (derivat of LNCaP) Human genital tract cell line adherent siRNA RNA-Interference Metafectene publication K. S. R. Sastry et al., J. Biol. Chem., Jul 2006; 281: 20891 - 20901 Link

EFO-27

 Human ovary adenocarcinoma cell line (cisplatin resistant) Human genital tract cell line adherent plasmid stable transfection K2 Transfection System application note

EFO-27

 Human ovary adenocarcinoma cell line (cisplatin resistant) Human genital tract cell line adherent plasmid K2 Transfection System publication S. Dilruba et al., Cells, 2020, 9: 515, doi:10.3390/cells9020515 Link

EFO-27

 Human ovary adenocarcinoma cell line (cisplatin resistant) Human genital tract cell line adherent plasmid K2 Transfection System application note

Flp-In T-REx HeLa

 Human cervix adenocarcinoma cell line (derivative of HeLa) Human genital tract cell line adherent plasmid stable transfection Metafectene PRO publication T. M. Nthiga et al., J. Cell Biol., 2021, 220, 6, doi.org/10.1083/jcb.202006128 Link

Flp-In T-REx HeLa

 Human cervix adenocarcinoma cell line (derivative of HeLa) Human genital tract cell line adherent plasmid CRISPR Metafectene PRO publication T. M. Nthiga et al., J. Cell Biol., 2021, 220, 6, doi.org/10.1083/jcb.202006128 Link

Flp-In TREx HeLa

 Human cervix adenocarcinoma cell line (derivative of HeLa) Human genital tract cell line adherent plasmid stable transfection Metafectene PRO publication T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 Link

Set Descending Direction

1-25 of 270

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Fax-order

Feel free to order by fax:
0049 89 32479952
Europe
0049 89 32479952
USA/Canada
01149 89 32479952
Australia
001149 89 32479952

Email-order

Feel free to order via email: order@biontex.com

Online-order

To view the correct product and freight prices, please select your region.

By continuing to browse this website, you agree to the use of cookies. Read more
© 2016 Biontex Laboratories GmbH. All rights reserved.